‘A Divorce But We Weren’t Even Married’ – Swiss Medtech Expects No EU MRA Before May
EU grace period might be allowed for Swiss devices in April
Executive Summary
A last-minute solution to the unresolved EU MRA issue is unlikely, so local manufacturers must prepare for Switzerland to be a “third country” to the EU after the MDR comes fully into force.
You may also be interested in...
Signs Of Hope But Obstacles Remain For Swiss Device MRA With EU
Without the MRA that allows unimpeded bilateral device trade between the EU and Switzerland, Swiss industry is having to find ways of limiting the damage that newly erected barriers will cause after the MDR comes into force.
EU Must Up Pressure To Secure Swiss Device MRA Or Transitional Arrangements
Patient care and device trade will suffer without urgent attention to the signing of the EU-Switzerland medtech mutual recognition agreement, say German health care products groups.
DTx And Drug Deal Sees Closed Loop Medicine And Teva Team Up On Precision Care
Medicines are still typically prescribed based on average effects in a population and rarely dose-optimized for the individual, says Closed Loop Medicine. The company sees a new strategic partnership with Teva UK as another step in advancing personalized medicine.